Omitting completion axillary lymph node dissection does not increase risk for death for patients with clinically node-negative breast cancer, but it does significantly improve arm distress.Data from ...

CHICAGO, IL (May 5, 2026) — A swarm of tiny, shape-changing, all-metal robots might someday deliver drugs and capture biopsy samples painlessly and then safely dissolve without the need for extraction ...

Good afternoon, and welcome to Castle Biosciences DecisionDx-Melanoma Webcast. As a reminder, today's webcast is being recorded. Drs. Guenther and Goldberg will begin with a presentation that follows ...

The management of axillary lymph nodes in breast cancer is continually evolving. Recent data now support omitting axillary lymph node dissection (ALND) in most patients with metastases in up to two ...

A lymph node biopsy is a procedure to take out all or part of a lymph node to check it for cancer cells. (If you have tumors only outside of your lymph nodes, your physician will biopsy that tissue ...

Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to ...

The absolute difference in 5-year regional-recurrence free survival was 2.35% between patients who received breast conserving therapy with and without SLNB, meeting the primary endpoint for ...

The 3-year axillary RFS rate was 99.2% with axillary lymph node dissection and 98.8% with less-invasive procedures. Less-invasive lymph node procedures are noninferior to axillary lymph node ...

Penile cancer, though rare, has a high mortality rate due to delayed diagnosis and lymph node metastasis. ILND is indicated for intermediate- or high-risk penile cancer, with specific criteria guiding ...

Omitting SLNB in older patients with early-stage, HR-positive, HER2-negative breast cancer showed similar safety and efficacy to performing the procedure. The BOOG 13-08 trial demonstrated comparable ...